Fundamental technology to support the early diagnosis of neurodevelopmental disorders from brain response at the time of medication
Tokyo, February 8, 2019 --- Hitachi, Ltd. (TSE: 6501, Hitachi), Jichi Medical University (JMU), International University of Health and Welfare (IUHW) and Chuo University (Chuo-U) have developed fundamental technology to support the early differential diagnosis of concurrent autism spectrum disorder(1) (ASD) in patients with attention-deficit hyperactivity disorder(2) (ADHD).